Vevo Therapeutics
Healthcare AI
Drug discovery
Seed
Vevo Therapeutics is a biotechnology company in the AI healthcare / drug discovery space that develops an in vivo drug discovery platform and next-generation AI models to generate single-cell, multi-patient data for better drug discovery. The company is known for its Mosaic platform and for generating the Tahoe-100M single-cell atlas to train AI models on drug-perturbed diseased cells.
Company Details
- Website
- vevo.ai
- Headquarters
- South San Francisco, California, United States
- Founded
- 2022
- Funding
- $12M
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring